Published in Graefes Arch Clin Exp Ophthalmol on November 14, 2003
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68
Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis (2006) 1.18
Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol (2011) 1.12
The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res (2009) 1.11
Autofluorescence characteristics of normal foveas and reconstruction of foveal autofluorescence from limited data subsets. Invest Ophthalmol Vis Sci (2005) 1.05
Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis (2008) 0.96
The role of lutein in eye-related disease. Nutrients (2013) 0.89
Heritability of the spatial distribution and peak density of macular pigment: a classical twin study. Eye (Lond) (2012) 0.82
Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS). Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous (2016) 0.78
Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Association of age and macular pigment optical density using dual-wavelength autofluorescence imaging. Clin Ophthalmol (2013) 0.78
Autofluorescence and optical coherence tomography findings in optic disc pit-associated maculopathy: case series. Int Ophthalmol (2011) 0.78
[cSLO digital fundus autofluorescence imaging]. Ophthalmologe (2005) 0.77
Changes of macular pigment optical density in elderly eyes: a longitudinal analysis from the MARS study. Int J Retina Vitreous (2016) 0.76
The use of heterochromatic flicker photometry to determine macular pigment optical density in a healthy Australian population. Graefes Arch Clin Exp Ophthalmol (2014) 0.76
Fundus autofluorescence in chronic essential hypertension. J Ophthalmic Vis Res (2015) 0.75
Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density. Clin Ophthalmol (2016) 0.75
Influence of macular oedema on the measurement of macular pigment optical density. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2000) 8.10
The Wisconsin age-related maculopathy grading system. Ophthalmology (1991) 7.62
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA (1994) 5.43
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol (1993) 2.24
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr (1995) 2.21
Preliminary identification of the human macular pigment. Vision Res (1985) 2.06
Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96
Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci (1997) 1.72
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci (2001) 1.70
Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res (1997) 1.62
The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci (1984) 1.60
Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci (2001) 1.45
Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis (2001) 1.43
Macular pigment and age related macular degeneration. Br J Ophthalmol (1999) 1.39
Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci (2000) 1.34
Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34
Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29
The Alabama Age-Related Macular Degeneration Grading System for donor eyes. Invest Ophthalmol Vis Sci (1998) 1.26
The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol (1997) 1.25
Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res (2003) 1.21
Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci (2000) 1.08
Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci (2002) 1.07
Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B Biol Sci (1982) 1.05
Historic perspectives. Macular yellow pigment. The first 200 years. Retina (1981) 1.05
Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res (1999) 1.01
Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci (1991) 0.99
Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. Invest Ophthalmol Vis Sci (2001) 0.98
Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci (1992) 0.96
Optical density of human macular pigment. Vision Res (1987) 0.86
Macular pigment optical density measurement: a novel compact instrument. Ophthalmic Physiol Opt (2000) 0.81
Wavelength dependence of the Stiles-Crawford effect explained by perception of backscattered light from the choroid. J Opt Soc Am A Opt Image Sci Vis (2001) 0.80
Macular pigment and the colour-specificity of visual evoked potentials. Vision Res (1998) 0.77
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet (1993) 3.62
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11
Tears of detached retinal pigment epithelium. Br J Ophthalmol (1981) 3.08
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31
The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17
Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14
In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10
Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07
Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07
Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet (2000) 2.02
Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99
Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90
A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88
A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84
A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81
A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80
A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79
A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77
Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75
Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74
Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74
Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74
Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71
Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70
Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68
Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66
Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66
Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65
Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64
Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol (1997) 1.63
Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab (1997) 1.58
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol (1994) 1.55
Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain (1987) 1.54
Senile disciform macular degeneration: features indicating suitability for photocoagulation. Br J Ophthalmol (1979) 1.54
Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51
On the retinal vasculature of the human fovea. Exp Eye Res (1974) 1.50
Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49
Low vision services for vision rehabilitation in the United Kingdom. Br J Ophthalmol (2002) 1.47
Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics (1991) 1.46
Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Arch Dis Child (1977) 1.44
[Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study]. Ophthalmologe (2002) 1.43
Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol (1975) 1.42
Histopathology of incipient fundus flavimaculatus. Ophthalmology (1991) 1.42
Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41
Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol (1993) 1.41
A comparative histopathological study of argon and krypton laser irradiations of the human retina. Br J Ophthalmol (1979) 1.41
Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40
The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39
A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity. J Med Genet (1998) 1.39
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology (1989) 1.38
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye (Lond) (2009) 1.38
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35
Visual prognosis of disciform degeneration in myopia. Ophthalmology (1983) 1.34
Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol (1999) 1.34
Confocal imaging of the fundus using a scanning laser ophthalmoscope. Br J Ophthalmol (1992) 1.32
A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol (1999) 1.31
Sorsby's fundus dystrophy. A clinical study. Ophthalmology (1989) 1.30
Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol (2000) 1.29
Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology (1993) 1.29
Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye (Lond) (1994) 1.29
Mutations in the RP2 gene cause disease in 10% of families with familial X-linked retinitis pigmentosa assessed in this study. Am J Hum Genet (1999) 1.28
Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol (2005) 1.27
Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol (2000) 1.27
Ocular abnormalities in Alagille syndrome. Ophthalmology (1999) 1.25
X-linked recessive fundus dystrophies and their carrier states. Trans Ophthalmol Soc U K (1970) 1.25
Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthalmol (1988) 1.25
Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol (2006) 1.24
Sickle cell retinopathy in young children in Jamaica. Br J Ophthalmol (1982) 1.24
Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol (1976) 1.24
Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24
Retinitis pigmentosa and retinal oedema. Br J Ophthalmol (1978) 1.23
Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1. Arch Ophthalmol (2001) 1.22